Navigation Links
Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference
Date:4/27/2009

1:30 a.m. luncheon on Monday, will discuss the need for scientists to become more effective communicators about vaccines. "It is incumbent on scientists to stand up for the science," he said. "No venue is too small." He urges scientists to reach out to ordinary citizens in venues ranging from PTA meetings to local high schools to explain the scientific method and discuss the safety of vaccines. "Science is wonderfully self-correcting," Dr. Offit said. "We are paying a price for standing back from the science that exonerates vaccines as a cause of chronic disorders like autism. Now, alarmingly, vaccine preventable diseases are starting to come back."

The Merieux Award is named for Dr. Charles Merieux, a French scientist and visionary who devoted his life to vaccines for the prevention of infectious disease. The company he developed from his father's laboratory eventually became sanofi pasteur, the world's largest vaccine maker. The Merieux Award is underwritten by an unrestricted educational grant from sanofi pasteur.

Other Top Scientists to Lecture

Harold S. Margolis, MD, director of the Pediatric Dengue Vaccine Initiative of the International Vaccine Institute in Seoul, Korea, will deliver the Mary Lou Clements-Mann Memorial Lecture on Vaccine Sciences at 8:00 a.m. on Tuesday. He will focus on the quest for a vaccine against dengue fever, which kills 20,000 and sickens more than two million people every year. The lecture is named after Mary Lou Clements-Mann, an immunologist at Johns Hopkins University who was killed in a plane crash in 1998 along with her husband, Jonathan Mann, founding director of the World Health Organization's global AIDS program.

Steven Black, MD, adjunct professor of pediatrics at the Center for Global Health at Cincinnati Children's Hospital, will present the conference's Robert Austrian Memorial Lecture titled, The Ever Changing Landscape of Pneumococca
'/>"/>

SOURCE National Foundation for Infectious Diseases
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
2. Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist
3. Pixantrone Increases Progression-Free Survival by 81% Compared to Standard Chemotherapeutic Agents in Phase III Relapsed Aggressive non-Hodgkins Lymphoma Trial
4. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
5. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
6. Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer
7. Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients
8. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
9. Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects
10. PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies
11. New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... ROCKVILLE, Md. , May 20, 2013  Neuralstem, ... Eva Feldman , MD, PhD, principal investigator, presented ... neural stem cell (NSI-566) trial in the treatment of ... ,s disease) at the neuro diabetes special medical ... Friday. In a talk called "Recent Therapeutic Advances in ...
(Date:5/20/2013)... , May 20, 2013 Decision Resources, ... firms for pharmaceutical and healthcare issues, finds that ... offering a greater effect on quality of life ... Given the high level of subjectivity and variability ... interviewed thought leaders state that it is difficult ...
(Date:5/19/2013)... 20, 2013  Whole-cell pertussis vaccines were more effective ... a large recent outbreak, according to a new Kaiser ... vaccines, also called DTwP, were available from the 1940s ... ultimately led to the development of acellular pertussis vaccines, ... the United States had switched ...
Breaking Medicine Technology:Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4
... Spirogen Limited (the "Company") and Celtic Therapeutics Holdings ... Phase II clinical trial of SG2000 in ovarian cancer. ... Institute (NCI) of the USA, and is now actively ... II study will evaluate the overall response rate of ...
... Sept. 15 AstraZeneca (NYSE: AZN ... Drug Administration (FDA) has extended the time to ... (NDA) for ticagrelor (BRILINTA). (Logo: ... the FDA extended the Prescription Drug User Fee ...
Cached Medicine Technology:Commencement of a Phase II Clinical Trial of SG2000 in Ovarian Cancer 2Commencement of a Phase II Clinical Trial of SG2000 in Ovarian Cancer 3U.S. Food and Drug Administration Extends Review Timeline for BRILINTA (Ticagrelor) New Drug Application 2
(Date:5/20/2013)... This summer, digital health leaders from across ... pilgrimage to San Diego, CA, the emerging digital health ... Summit produced by Living in Digital Times. ... the latest digital health innovations, exchange new information, share ... of industry’s most brilliant thinkers and doers, while elevating ...
(Date:5/20/2013)... By Dennis Thompson HealthDay Reporter , , MONDAY, ... with attention deficit-hyperactivity disorder (ADHD) are twice as likely ... the disorder when they were young, a new 30-year ... ADHD tended to have a higher body-mass index (BMI) ... of the disorder. Socioeconomics made no difference; well-off ...
(Date:5/20/2013)... subdural hematoma (PFSDH) is a serious and rare condition ... appropriate treatment, there,s an excellent chance of good long-term ... study in the May issue of Neurosurgery ... Neurological Surgeons . The journal is published by ... Wolters Kluwer Health . , The results support an ...
(Date:5/20/2013)... Philadelphia, PA (May 21, 2013) Wolters ... its Lippincott Williams & Wilkins (LWW) published journals ... annual awards competition recognizes member articles and publications ... , "It,s a tremendous honor to be recognized ... have become synonymous in the industry with quality, ...
(Date:5/20/2013)... Today, Allayo announced the debut of their ... application called Allie helps health care consumers who are ... arrange for quality health care. Ideal for busy individuals ... technology and access to personalized service from certified medical ... care needs are being met. Allie is being previewed ...
Breaking Medicine News(10 mins):Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 2Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 3Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 2Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 3Health News:Wolters Kluwer Health receives 13 awards from the ASHPE 2Health News:Allayo Debuts Virtual Health Assistant At HealthBeat 2013 2
... application remains elusive, expert says , , WEDNESDAY, Feb. 25 ... of scientists has created two chemical compounds that appear ... a lack of oxygen. , "It is known that ... brain, which can be produced during hypoxia, it leads ...
... Chairman; Siegrist Takes on Executive PostSOUTH BEND, Ind., Feb. 25 ... transition from president and chief executive officer to chairman of ... Rick Siegrist, M.B.A., president of a Press Ganey subsidiary, PatientFlow ... Ganey Board of Directors, will take on the top executive ...
... White House to ,Protect the Safety Net, , WASHINGTON, ... two leading long-term care advocacy organizations, the American Health ... Home Care, today praised and thanked U.S. Representatives Earl ... and Ginny Brown-Waite (R-FL) for sending a new letter ...
... Laboratories(TM), a division of Ben Venue Laboratories, Inc., today ... product is AP rated and is equivalent to Imitrex(R) ... indicated for 1) the acute treatment of migraine attacks ... of cluster headache episodes. Sumatriptan Succinate Injection is not ...
... NEW YORK, February 25, 2009 The National ... awarded The City College of New York (CCNY) ... million grant to implement a unique partnership in ... award is funded by NCI,s U54 program, an ...
... COLORADO SPRINGS, Colo., Feb. 25 /PRNewswire/ -- ... the National Academy of Sciences, (NAS) report. Recognizing ... NAS report provides insight toward the path forward. ... improve and enhance the forensic sciences have been propounded, ...
Cached Medicine News:Health News:Compounds Found to Protect Rabbits From Cerebral Palsy 2Health News:Changing of the Guard at Press Ganey 2Health News:Changing of the Guard at Press Ganey 3Health News:Pomeroy, Berkley, Capito, Brown-Waite Urge Obama Administration to Protect Seniors' Care 2Health News:Pomeroy, Berkley, Capito, Brown-Waite Urge Obama Administration to Protect Seniors' Care 3Health News:Bedford Laboratories(TM) to Begin Shipping Sumatriptan Succinate Injection 2Health News:NIH awards $15.9 million to CCNY and Memorial Sloan-Kettering to create partnership 2
The Stat Profile pHOx CO-Oximeter is intended for use in those situations where a more comprehensive profile beyond the measured hematocrit, hemoglobin, and SO2% offered by the Stat Profile pHOx ...
Maxi-Therm® hyper-hypothermia water blankets from Cincinnati Sub-Zero are designed for single-patient use. These blankets are easy to clean, stain resistant and ideal for isolation cases....
The °CureWrap is one-piece garment offers maximum available surface coverage, while avoiding the sterilized fields of operation....
... Oximetry Data Management Program is a ... with the FingerPrint® Sleep Hand-Held Pulse ... PM, Inc. catalog #3389 Interface Cable, ... sleep screening, oxygen therapy validation, and/or ...
Medicine Products: